TuHURA Biosciences, Inc. (HURA) financial statements and ratios from SEC XBRL: revenue $0.00 (TTM). Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $0.00 |
| Return on Equity | -165.5% |
| Debt / Equity | 0.19 |
| Current Ratio | 0.18 |
| Price / Book | 6.87 |
| FCF Yield | -34.8% |
| Altman Z-Score | 0.96 (distress) |
| Sector P/E (Healthcare) | 21.7 |
HURA overview · HURA earnings · HURA KPIs · HURA investor relations · HURA ownership · HURA peers · HURA filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.